Dan Ferry | IR, LifeSci Advisors |
Fahar Merchant | President & CEO |
Liz Williams | CFO |
Matt Biegler | Oppenheimer |
David Martin | Bloom Burton |
Catherine Novack | JonesTrading |
Arthur He | H.C. Wainwright |
Greetings, and welcome to the Medicenna Therapeutics Corp.
First Quarter Fiscal 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.